Computed tomography-based assessment of abdominal adiposity changes and their impact on metabolic alterations following bariatric surgery

World Journal of Surgery

Volumn 39, Issue 2, 2015, Pages 417-423

  Galanakis, Christos G ^a   Daskalakis, Markos ^a   Manios, Andreas ^a   Xyda, Argyro ^a   Karantanas, Apostolos H ^a   Melissas, John ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ABDOMINAL SUBCUTANEOUS FAT; ADULT; BLOOD; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GASTRECTOMY; GASTROPLASTY; HUMAN; INTRAABDOMINAL FAT; MALE; METABOLISM; MIDDLE AGED; OBESITY; OBESITY, MORBID; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDY; RADIOGRAPHY; WEIGHT REDUCTION;

ADIPOSITY; ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; GASTRECTOMY; GASTROPLASTY; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROSPECTIVE STUDIES; SUBCUTANEOUS FAT, ABDOMINAL; TOMOGRAPHY, X-RAY COMPUTED; WEIGHT LOSS;

EID: 84922099032     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-014-2826-2     Document Type: Article

References (37)

1. Wang Y, Rimm EB, Stampfer MJ et al (2005) Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 81:555-563
2. Després JP, Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 14:881-887
3. Fox CS, Massaro JM, Hoffmann U et al (2007) Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 3:39-48
4. Matsuzawa Y (2008) The role of fat topology in the risk of disease. Int J Obes (Lond) 32:S83-S92
5. Busetto L, Tregnaghi A, Bussolotto M et al (2000) Visceral fat loss evaluated by total body magnetic resonance imaging in obese women operated with laparoscopic adjustable silicone gastric banding. Int J Obes Relat Metab Disord 24:60-69
6. Heath ML, Kow L, Slavotinek JP et al (2009) Abdominal adiposity and liver fat content 3 and 12 months after gastric banding surgery. Metabolism 58:753-758
7. Pontiroli AE, Pizzocri P, Librenti MC et al (2002) Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 87:3555-3561
8. Weiss R, Appelbaum L, Schweiger C et al (2009) Short-term dynamics and metabolic impact of abdominal fat depots after bariatric surgery. Diabetes Care 32:1910-1915
9. Carroll JF, Franks SF, Smith AB et al (2009) Visceral adipose tissue loss and insulin resistance 6 months after laparoscopic gastric banding surgery: a preliminary study. Obes Surg 19:47-55
10. Marantos G, Daskalakis M, Karkavitsas N et al (2011) Changes in metabolic profile and adipoinsular axis in morbidly obese premenopausal females treated with restrictive bariatric surgery. World J Surg 35:2022-2030. doi:10.1007/s00268-011-1165-9
11. Nishida C, Ko GT, Kumanyika S (2010) Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio. Eur J Clin Nutr 64:2-5
12. Mancia G, De Backer G, Dominiczak A et al (2007) 2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28:1462-1536
13. Grundy SM, Cleeman JI, Daniels SR et al (2005) American Heart Association; National Heart, Lung, and Blood Institute Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 25:2735-2752
14. Shuster A, Patlas M, Pinthus JH et al (2012) The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br J Radiol 85:1-10
15. Fabbrini E, Magkos F, Mohammed BS et al (2009) Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 106:15430-15435
16. Speliotes EK, Massaro JM, Hoffmann U et al (2010) Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 51:1979-1987
17. Therkelsen KE, Pedley A, Speliotes EK et al (2013) Intramuscular fat and associations with metabolic risk factors in the Framingham Heart Study. Arterioscler Thromb Vasc Biol 33:863-870
18. O'Rourke RW (2009) Molecular mechanisms of obesity and diabetes: at the intersection of weight regulation, inflammation, and glucose homeostasis. World J Surg 33:2007-2013. doi:10.1007/s00268-009-0067-6
19. Ibrahim MM (2010) Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 11:11-18
20. Peinado JR, Jimenez-Gomez Y, Pulido MR et al (2010) The stromal-vascular fraction of adipose tissue contributes to major differences between subcutaneous and visceral fat depots. Proteomics 10:3356-3366
21. Hutley L, Prins JB (2005) Fat as an endocrine organ: relationship to the metabolic syndrome. Am J Med Sci 330:280-289
22. Mauriège P, Marette A, Atgié C et al (1995) Regional variation in adipose tissue metabolism of severely obese premenopausal women. J Lipid Res 36:672-684
23. Mittelman SD, Van Citters GW, Kirkman EL et al (2002) Extreme insulin resistance of the central adipose depot in vivo. Diabetes 51:755-761
24. Sniderman AD, Bhopal R, Prabhakaran D et al (2007) Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesis. Int J Epidemiol 36:220-225
25. Hallgreen CE, Hall KD (2008) Allometric relationship between changes of visceral fat and total fat mass. Int J Obes (Lond) 32:845-852
26. Ramalho R, Guimarães C, Gil C et al (2009) Morbid obesity and inflammation: a prospective study after adjustable gastric banding surgery. Obes Surg 19:915-920
27. Pardina E, Ferrer R, Baena-Fustegueras JA et al (2012) Only C-reactive protein, but not TNF-a or IL6, reflects the improvement in inflammation after bariatric surgery. Obes Surg 22:131-139
28. Ridker PM, Danielson E, Fonseca FA et al (2008) Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J 20:2195-2207
29. Tzotzas T, Evangelou P, Kiortsis DN (2011) Obesity, weight loss and conditional cardiovascular risk factors. Obes Rev 12:e282-e289
30. Ledoux S, Coupaye M, Essig M et al (2010) Traditional anthropometric parameters still predict metabolic disorders in women with severe obesity. Obesity (Silver Spring) 18:1026-1032
31. Giles JT, Allison M, Blumenthal RS et al (2010) Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum 62:3173-3182
32. Visser M, Bouter LM, McQuillan GM et al (1999) Elevated C-reactive protein levels in overweight and obese adults. J Am Med Assoc 8:2131-2135
33. Rao SR (2012) Inflammatory markers and bariatric surgery: a meta-analysis. Inflamm Res 61:789-807
34. Anty R, Bekri S, Luciani N et al (2006) The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, type 2 diabetes, and NASH. Am J Gastroenterol 101:1824-1833
35. Hakeam HA, O'Regan PJ, Salem AM et al (2009) Inhibition of C-reactive protein in morbidly obese patients after laparoscopic sleeve gastrectomy. Obes Surg 19:456-460
36. Brenner DJ, Hall EJ (2007) Computed tomography - an increasing source of radiation exposure. N Engl J Med 357:2277-2284
37. Smith-Bindman R, Lipson J, Marcus R et al (2009) Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 169:2078-2086